×
For best experience we recommend to activate Javascript in your browser.
Nucleostemin antibody (C-Term)
The Rabbit Polyclonal anti-Nucleostemin antibody has been validated for WB, ELISA and IHC. It is suitable to detect Nucleostemin in samples from Human.
Quick Overview for Nucleostemin antibody (C-Term) (ABIN2257010)
Target
See all Nucleostemin (GNL3) Antibodies
Nucleostemin (GNL3)
(Guanine Nucleotide Binding Protein-Like 3 (Nucleolar) (GNL3))
Reactivity
All reactivities for Nucleostemin antibodies
Human
Host
All hosts for Nucleostemin antibodies
Rabbit
Clonality
All clonalities for Nucleostemin antibodies
Polyclonal
Conjugate
All conjugates for Nucleostemin antibodies
This Nucleostemin antibody is un-conjugated
Application
All applications for Nucleostemin antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-Nucleostemin Antibody
(hide)
Binding Specificity
All epitopes for Nucleostemin antibodies
C-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
E2IG3, CT (Nucleostemin, Guanine Nucleotide-binding Protein-Like 3, Nucleolar GTP-binding Protein 3, E2-induced Gene 3 Protein, Novel Nucleolar Protein 47, NNP47, NS)
Purification
Purified by ammonium sulfate precipitation.
Immunogen
Synthetic peptide selected from the C-term region of human E2IG3 (KLH).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for Nucleostemin
(hide)
Target
Nucleostemin (GNL3)
(Guanine Nucleotide Binding Protein-Like 3 (Nucleolar) (GNL3))
Alternative Name
E2IG3
NCBI Accession
NP_055181
UniProt
Q9BVP2
Recently viewed
(hide)
Chat with us , powered by LiveChat